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ABSTRACT 
Glycogen synthase kinase-3β (GSK-3β) has recently emerged, in the field of medicinal chemistry, as one of the most attractive 
therapeutic targets for type II diabetes. Phenylmethylene hydantoins (PMHs) forms strong interactions with the hinge region of 
GSK-3β; carbonyl oxygen at position 2 form a H-bonding with backbone nitrogen of Val135 and the NH at position 3 to the 
carbonyl oxygen of Asp133. The hydantoin ring was sandwiched between Ala83, on top, and Leu188, on the bottom. The aromatic 
ring is rotated out of plane from the hydantoin plane, allowing extensive interactions with the nucleotide-binding loop. Furthermore, 
the substituted benzylidene ring system builds an H-bonding interaction with the guanidine moiety of Arg141. Targeting Arg141 is 
important to improve the activity in the process of designing new derivatives because it is considered the selectivity residue for 
GSK-3β. 
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INTRODUCTION: 
The insulin insensitive form of diabetes, type 2 diabetes 
mellitus characterized by hyperglycaemia which is also 
known as elevated blood glucose concentrations, most 
frequently arises as a consequence of obesity, represents 
approximately 95% of the overall incidence of diabetes-
I. Additionally, diabetes related complications exert a 
heavy toll on patients with poor metabolic control
 1-5
. 
Most of kinase inhibitors act by competition with either 
ATP or metal-binding sites that are involved directly in 
the catalytic process. Over the past 15 years, there have 
been extensive efforts to understand and reduce the high 
attrition rates of drug candidates with an increased focus 
on physicochemical properties. The fruits of this labour 
have been the generation of numerous efficiency 
indices, metric-based rules and visualization tools to 
help guide medicinal chemists in the design of new 
compounds with more favorable properties. This deluge 
of information may have had the unintended 
consequence of further obfuscating molecular 
optimizations by the inability of these scoring functions, 
rules and guides to reach a consensus on when a 
particular transformation is identified as beneficial. In 
spite of the early discovery of insulin and its subsequent 
widespread use in the treatment of diabetes mellitus, and 
later discovery and use of sulfonylureas e.g. 
chlorpropamide, tolbutamide and biguanides viz. 
phenformin as oral hypoglycemic agents, the treatment 
of diabetes mellitus remains less than satisfactory. 
Insulin can only be administered intravenously due to its 
chemical nature, and therefore, is troublesome and 
inconvenient to use. Oral hypoglycemic agents tend to 
promote side effects such as excessive hypoglycemia or 
lactic acidosis. Glycogen synthase kinase-3β (GSK-3β) 
has recently emerged, in the field of medicinal 
chemistry, as one of the most attractive therapeutic 
targets for Type II diabetes. The full potential of GSK-
3β inhibitors is yet to be realized and the number of drug 
candidates being developed by both academic centers 
and pharmaceutical companies has increased 
exponentially in the last few years.
 
Glycogen synthase 
kinase-3β (gsk-3β) is a unique multifunctional 
serine/threonine kinase that is inactivated by 
phosphorylation in response to insulin binding; 
PKB/AKT phosphorylates GSK-3β on serine9, which 
prevents the enzyme from phosphorylating glycogen 
synthase. Unphosphorylated glycogen synthase is active 
& able to synthesize glycogen.
 
Phenylmethylene hydantoins (PMHs) forms strong 
interactions with the hinge region of GSK-3β; carbonyl 
oxygen at position 2 form a H-bonding with backbone 
nitrogen of Val135 and the NH at position 3 to the 
carbonyl oxygen of Asp133. The hydantoin ring was 
sandwiched between Ala83, on top, and Leu188, on the 
bottom. The aromatic ring is rotated out of plane from 
the hydantoin plane, allowing extensive interactions 
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with the nucleotide-binding loop. Furthermore, the 
substituted benzylidene ring system builds an H-
bonding interaction with the guanidine moiety of 
Arg141. Targeting Arg141 is important to improve the 
activity in the process of designing new derivatives 
because it is considered the selectivity residue for GSK-
3β. Design of potent and selective GSK-3β inhibitors 
should consider the following important hot spots 
 H-bonding interaction with the hinge region of 
Asp133 and Val135. 
 Targeting Arg141 and Gln185 amino acids. 
 Filling the Val70, Lys85 and Cys99 hydrophobic 
pocket. For example, keeping the hydantoin ring and 
chemical moiety at benzylidene ring system can 
afford potent and selective GSK-3β inhibitor. 
The wide chemical diversity of possible inhibitors and 
the existence of multiple sites for potential inhibition 
encourage researcher topursue the development of GSK-
3β inhibitors as potential drugs. Therefore it is 
worthwhile to develop further substituted GSK-3β 
inhibitors as antidiabetic agents 
1-4
.
 
MATERIAL AND METHODS: 
Docking of Designed Compounds The molecular 
docking was performed using Molegro Virtual Docker 
(MVD) 2006. 1.5 and CS Chem Office version 11.0. 
The docking scoring function of MolDock that we use is 
based on a piecewise linear potential (PLP) including 
new hydrogen bonding and electrostatic terms 
introduced. Structures of all the compounds were 
sketched using builder module of the program. The 
sketched structures were subjected to energy 
minimization using molecular mechanics (MM2) until 
the RMS gradient value became smaller than 0.1 
kcal/molA°. The energy minimized molecules were 
subjected to re-optimization via Austin model-1 (AM1) 
method until the RMS gradient attained a value smaller 
than 0.01 kcal/mol °A using MOPAC The descriptor 
values for all the molecules were calculated using 
“compute properties” module of program. The 
minimized molecule was saved as MOL file format
5
. 
Following Steps were used for docking through MVD: 
1) Importing and Preparing Molecules 
 File Import: - MVD supports PDB, Mol2, SDF, and 
its own XML-based format, 
 MVDML. 
 Adding a Molecular Surface 
 Predicting the Binding Site 
2) Running the Docking Simulation: - 
 By selecting Docking | Docking Wizard 
 Choosing Structures 
 Defining the Region of Interest 
3) Viewing the Results 
These designed analogs were docked in the ATP 
binding site of GSK-3β by Molegro Virtual Docker 
2006.1.5. 
RESULTS AND DISCUSSION: 
On the basis of literature study hydantoin analogs were 
designed. These designed analogs were docked in the 
ATP binding site of GSK-3β by Molegro Virtual Docker 
2006.1.5. 
Phenylmethylene hydantoins (PMH) forms strong 
interactions with the hinge region of GSK-3β; carbonyl 
oxygen at position 2 form a H-bonding with backbone 
nitrogen of Val135 and the NH at position 3 to the 
carbonyl oxygen of Asp200. 
Furthermore, the substituted benzylidene ring system 
builds an H-bonding interaction with the guanidine 
moiety of Arg141. Targeting Arg141 is important to 
improve the activity in the process of designing new 
derivatives because it is considered the selectivity 
residue for GSK-3β. Substitution at benzylidene ring 
system can afford potent and selective GSK-3β 
inhibitors as H (a-f). 
 
Table 1: Docking Score of Synthesized compound 
Comp. 
Code 
Synthesized Compound 
Mol Dock Score 
(E-Total) 
H-Bonds 
Interactions With 
Amino Acids 
H-a 
C
O
O
HN NH
O
O  
-113.32 
Arg 141 
Pro 136 
Tyr 134 
H-b 
C
O
O
HN NH
O
O
H3C
 
-126.06 
Asp 200 
Lys 183 
Asp 200 
H-c 
C
O
O
HN NH
O
O
Cl
 
-129.62 
Tyr 134 
Arg 141 
Pro 136 
Cys 199 
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H-d 
C
O
O
HN NH
O
O
H3C
 
-125.06 
Arg 141 
Pro 136 
Tyr 136 
Cys 199 
H-e 
C
O
O
HN NH
O
O
Cl
 
-127.93 
Val 135 
Asp 200 
Phe 201 
Glu 97 
H-f 
C
O
NH
H2C
COO
NH
H
N
O
O
 
-147.53 
Arg 141 
Asn 64 
Ile 62 
Glu 97 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The prototype pose of docked structure of a Hydantoin analogue. 
CONCLUSION: 
Glycogen synthase kinase-3β (GSK-3β) is a unique 
multifunctional serine/threonine kinase that is 
inactivated by phosphorylation in response to insulin 
binding; PKB/AKT phosphorylates GSK-3β on serine9, 
which prevents the enzyme from phosphorylating 
glycogen synthase. Unphosphorylated glycogen synthase 
is active & able to synthesize glycogen. 
Phenylmethylene hydantoins (PMH) forms strong 
interactions with the hinge region of GSK-3β; carbonyl 
oxygen at position 2 form a H-bonding with backbone 
nitrogen of Val135 and the NH at position 3 to the 
carbonyl oxygen of Asp133. 
The hydantoin ring was sandwiched between Ala83, on 
top, and Leu188, on the bottom. The aromatic ring is 
rotated out of plane from the hydantoin plane, allowing 
extensive interactions with the nucleotide-binding loop. 
Furthermore, the substituted benzylidene ring system 
builds an H-bonding interaction with the guanidine 
moiety of Arg141. Targeting Arg141 is important to 
improve the activity in the process of designing new 
derivatives because it is considered the selectivity 
residue for GSK-3β. Encouraged by the above literature 
we tried to prepare the analogs in which keeping the 
hydantoin ring, and substitution at benzylidene ring 
system, apart from this hydantoin ring is replaced with 
bioisoesteric substitute ring (like rhodadine, oxindole) 
can afford potent and selective GSK-3β inhibitor.
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